About SpectrumAi
SpectrumAi develops innovative solutions for life-changing therapies, including Twyll, a next-generation electronic health record (EHR) modernizing Applied Behavior Analysis (ABA) therapy through transformative, data-driven tools. Twyll simplifies documentation and improves supervisor oversight with a modern interface, while Patterns ABA network analytics enables the transition to value-based contracting through objective data and analytics.
Los Angeles, CaliforniaHeadquarters
2021Year Founded
$28.2MTotal Funding
SERIES_ACompany Stage
AI & Machine Learning, HealthcareIndustries
11-50Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Short-term Disability
Long-term Disability
Mental Health Support
Remote Work Options
Flexible Work Hours
Unlimited Paid Time Off
401(k) Retirement Plan
Company Equity
Professional Development Budget
Risks
Competition from startups like Elemy, which raised $219M, poses a threat.
Scaling globally is challenging due to varying ABA therapy regulations.
Dependence on continuous funding may be unsustainable if market conditions change.
Differentiation
SpectrumAi focuses on modernizing ABA therapy with data-driven solutions.
The company collaborates with global clinical leaders in autism care.
SpectrumAi's Twyll and Patterns platforms enhance data capture and measurement in ABA therapy.
Upsides
Increased telehealth adoption enhances SpectrumAi's reach in delivering ABA therapy.
Growing interest in personalized medicine aligns with SpectrumAi's data-driven approach.
Rising demand for digital health in pediatric care expands SpectrumAi's market presence.
Funding
Total raised$28.21 M
Latest valuation$100.00 M
StageSERIES_A
$20
$100.00 MSEED
5/31/2022$9
$45.00 M